Must all living donor compensation be viewed as valuable consideration? [2]

American Journal of Transplantation

Volumn 7, Issue 5, 2007, Pages 1309-1310

  Gaston, Robert S ^a   Danovitch, Gabriel M ^b   Epstein, Richard A ^c,d   Kahn, Jeffrey P ^e   Matas, Arthur J ^e   Schnitzler, Mark A ^f  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CHICAGO LAW SCHOOL   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPENSATION; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; KIDNEY DONOR; LETTER; LIVING DONOR; MEDICAL LITERATURE; PRIORITY JOURNAL; REIMBURSEMENT; RISK ASSESSMENT; RISK MANAGEMENT;

EID: 34247401364     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01739.x     Document Type: Letter

References (6)

1. Gaston RS, Danovitch GM, Epstein RA, Kahn JP, Matas AJ, Schnitzler MA. Limiting financial disincentives in live organ donation: A rational solution to the kidney shortage. Am J Transplant 2006 6 : 2548 2555.
2. Danovitch GM, Leichtman AB. Kidney vending: The "Trojan Horse" of organ transplantation. Clin J Am Soc Nephrol ePress doi: 10.2215/CJN. 03030906, 4 October 2006.
3. Matas AJ. The case for living kidney sales: Rationale, objections and concerns.[see comment]. Am J Transplant 2004 4 : 2007 2017.
4. Klarenbach S. Letter to the editor. Am J Transplant in press).
5. Fox MD. The price is wrong: The moral cost of living donor inducements. Am J Transplant 2006 6 : 2529 2530.
6. Ethics Committee of the Transplantation Society. A report of the Amsterdam Forum on the Care of the Live Kidney Donor: Data and medical guidelines. Transplantation 2005 79 : S53 S66.